Fill-Finish Solution
Supporting a Global Strategy to Bring Medicine to Market Faster

A guest post by Ima Life 5 min Reading Time

Related Vendors

Ima Life is proud to have made a significant contribution to the inauguration of Bayer’s latest facility in Berlin, Germany by supplying the most advanced aseptic processing technologies and implementing high-tech robotics for superior efficiency, flexibility and performance.

Bayer needed to count on the latest-generation technologies, high-performance equipment and the reliability of a consolidated player in the market. The choice fell on Ima Life with its fully robotic, aseptic, fill-finish solution: Injecta. (Source:  Ima Life)
Bayer needed to count on the latest-generation technologies, high-performance equipment and the reliability of a consolidated player in the market. The choice fell on Ima Life with its fully robotic, aseptic, fill-finish solution: Injecta.
(Source: Ima Life)

November 2023 saw the inauguration of a new Bayer facility in Berlin, Germany which is dedicated to producing parenteral medicines. In the context of a billion-dollar investment program which aims to boost the company’s pharmaceutical production capabilities and bring medicine from concept to market even faster in the future, Bayer needed to count on the latest-generation technologies, high-performance equipment and the reliability of a consolidated player in the market. The choice fell on Ima Life with its fully robotic, aseptic, fill-finish solution: Injecta.

The three key objectives